McLaughlin J - Search Results

1

Signaling by ABL oncogenes through cyclin D1.

Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF. Afar DE, et al. Among authors: mclaughlin j. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9540-4. doi: 10.1073/pnas.92.21.9540. Proc Natl Acad Sci U S A. 1995. PMID: 7568169 Free PMC article.

2

IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Wong S, McLaughlin J, Cheng D, Shannon K, Robb L, Witte ON. Wong S, et al. Among authors: mclaughlin j. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11630-5. doi: 10.1073/pnas.2035020100. Epub 2003 Sep 19. Proc Natl Acad Sci U S A. 2003. PMID: 14500898 Free PMC article.

3

Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.

McLaughlin J, Cheng D, Singer O, Lukacs RU, Radu CG, Verma IM, Witte ON. McLaughlin J, et al. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20501-6. doi: 10.1073/pnas.0710532105. Epub 2007 Dec 13. Proc Natl Acad Sci U S A. 2007. PMID: 18079287 Free PMC article.

4

The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.

Gishizky ML, McLaughlin J, Pendergast AM, Witte ON. Gishizky ML, et al. Among authors: mclaughlin j. Oncogene. 1991 Aug;6(8):1299-306. Oncogene. 1991. PMID: 1886706

5

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Kelliher MA, et al. Among authors: mclaughlin j. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6649-53. doi: 10.1073/pnas.87.17.6649. Proc Natl Acad Sci U S A. 1990. PMID: 2204061 Free PMC article.

6

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Mol Cell Biol. 1989 May;9(5):1866-74. doi: 10.1128/mcb.9.5.1866-1874.1989. Mol Cell Biol. 1989. PMID: 2747638 Free PMC article.

7

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

McLaughlin J, Chianese E, Witte ON. McLaughlin J, et al. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6558-62. doi: 10.1073/pnas.84.18.6558. Proc Natl Acad Sci U S A. 1987. PMID: 3498165 Free PMC article.

8

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON. Goga A, et al. Among authors: mclaughlin j. Cell. 1995 Sep 22;82(6):981-8. doi: 10.1016/0092-8674(95)90277-5. Cell. 1995. PMID: 7553858 Free article.

9

Genetic approaches to defining signaling by the CML-associated tyrosine kinase BCR-ABL.

Afar DE, Goga A, Cohen L, Sawyers CL, McLaughlin J, Mohr RN, Witte ON. Afar DE, et al. Among authors: mclaughlin j. Cold Spring Harb Symp Quant Biol. 1994;59:589-94. doi: 10.1101/sqb.1994.059.01.067. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587117 Review. No abstract available.

10

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.

Sawyers CL, McLaughlin J, Witte ON. Sawyers CL, et al. Among authors: mclaughlin j. J Exp Med. 1995 Jan 1;181(1):307-13. doi: 10.1084/jem.181.1.307. J Exp Med. 1995. PMID: 7807010 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,833 results

Search Page

Filters